BlackRock Group’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.03M | Buy |
153,173
+49,899
| +48% | +$661K | ﹤0.01% | 1747 |
|
|
2016
Q3 | $2.45M | Buy |
103,274
+5,881
| +6% | +$139K | ﹤0.01% | 1473 |
|
|
2016
Q2 | $2.81M | Buy |
97,393
+6,416
| +7% | +$185K | ﹤0.01% | 1352 |
|
|
2016
Q1 | $2.91M | Buy |
90,977
+11,347
| +14% | +$363K | ﹤0.01% | 1306 |
|
|
2015
Q4 | $3.41M | Buy |
79,630
+857
| +1% | +$36.6K | ﹤0.01% | 1223 |
|
|
2015
Q3 | $2.77M | Buy |
78,773
+1,886
| +2% | +$66.4K | ﹤0.01% | 1316 |
|
|
2015
Q2 | $3.53M | Buy |
76,887
+13,145
| +21% | +$604K | ﹤0.01% | 1266 |
|
|
2015
Q1 | $2.99M | Buy |
63,742
+2,350
| +4% | +$110K | ﹤0.01% | 1306 |
|
|
2014
Q4 | $1.95M | Buy |
61,392
+3,276
| +6% | +$104K | ﹤0.01% | 1481 |
|
|
2014
Q3 | $1.38M | Sell |
58,116
-1,969
| -3% | -$46.7K | ﹤0.01% | 1582 |
|
|
2014
Q2 | $1.8M | Sell |
60,085
-34,835
| -37% | -$1.04M | ﹤0.01% | 1493 |
|
|
2014
Q1 | $2.51M | Sell |
94,920
-2,089
| -2% | -$55.2K | ﹤0.01% | 1407 |
|
|
2013
Q4 | $2.44M | Buy |
97,009
+8,185
| +9% | +$206K | ﹤0.01% | 1382 |
|
|
2013
Q3 | $1.82M | Buy |
88,824
+13,649
| +18% | +$279K | ﹤0.01% | 1509 |
|
|
2013
Q2 | $1.5M | Buy |
+75,175
| New | +$1.5M | ﹤0.01% | 1455 |
|